Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-003626·HIGHBRIDGE CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
Inmune Bio Inc
Common Stock, par value $0.001 per share · CUSIP: 45782T105
Event date: 2025-06-30
- Filing-level shares
- 1,454,400.00
- Percent of class
- 5.2%
- Highbridge Capital Management, LLC
Shares: 1,454,400.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003626
- Form type
- SCHEDULE 13G/A
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership